Tag: psoriasis

Novartis Confirm High Efficacy and Favorable Safety Profile of Cosentyx®

clinical-trial
Novartis real-world evidence confirms high efficacy, long-term response and favorable safety profile of Cosentyx® in clinical practice. Data from five real-world evidence (RWE) and observational st...

Amgen to Acquire Rights for Otezla® for $13.4bn

amgen
Amgen announced that it has entered into an agreement with Celgene Corporation in connection with its previously announced merger with Bristol-Myers Squibb Company to acquire worldwide rights to Otezl...

Can-Fite BioPharma Signed Agreement with Kyongbo Pharm to Distribute Piclidenoson

pharma-distribution
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, announced it has signed a distribution a...

FDA Approved Unique Topical Lotion for Plaque Psoriasis

Bausch Health Companies Inc. and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, announced that the U.S. Food and Drug Administration...

Studies Confirm Positive Long-Term Safety Profile of CIMZIA

UCB, a global biopharmaceutical company, today announced new data supporting the long-term safety of CIMZIA® (certolizumab pegol), the only Fc-free, PEGylated anti-Tumor Necrosis Factor (TNF), in pati...

Novartis Psoriasis Drug Shows High Results First Time in China

Results strengthen unique position of Cosentyx as a rapid and long-lasting complete treatment of psoriatic disease, with over 200,000 patients treated worldwide. Novartis announced today new data i...